Parabilis director granted 20,215 stock options
Parabilis Medicines director Yeshwant Krishna received a grant of stock options as compensation.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Parabilis Medicines director Yeshwant Krishna received a grant of stock options as compensation. The award covers 20,215 options to buy common stock at an exercise price of $20.00 per share, expiring on June 8, 2036. These options vest and become exercisable in full on the earlier of June 9, 2027 or the company’s next annual meeting of stockholders, contingent on his continued service. After this grant, he holds 20,215 derivative securities directly.
Insider Trade Summary
Grant/Award: 20,215 shares
Grant/Award
1 txn
Insider
Yeshwant Krishna
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 20,215 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,215 contracts (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 20,215 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Options granted: 20,215 options
Exercise price: $20.00 per share
Expiration date: June 8, 2036
+2 more
5 metrics
Options granted
20,215 options
Stock Option (Right to Buy) grant on June 9, 2026
Exercise price
$20.00 per share
Exercise price for common stock under the option
Expiration date
June 8, 2036
Option expiration for the granted stock options
Post-grant derivative holdings
20,215 derivative securities
Total stock options held directly after this grant
Vesting trigger date
June 9, 2027 or next annual meeting
Earlier date determines full vesting, subject to continued service
Key Terms
Stock Option (Right to Buy), exercise price, Common Stock, annual meeting of stockholders
4 terms
Stock Option (Right to Buy) financial
"Security title is listed as "Stock Option (Right to Buy)" in the filing."
exercise price financial
"The transaction shows an exercise price of 20.0000 per underlying share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"The underlying security title is identified as Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
annual meeting of stockholders financial
"Options vest on June 9, 2027 or the date of the issuer's next annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Parabilis Medicines (PBLS) report for Yeshwant Krishna?
Parabilis Medicines reported that director Yeshwant Krishna received a grant of 20,215 stock options. These options give him the right to buy common shares at $20.00 each as part of his compensation package, rather than reflecting an open-market stock purchase.
How many Parabilis Medicines (PBLS) options were granted to the director and at what price?
The director was granted 20,215 stock options with an exercise price of $20.00 per share. This means he can later purchase up to 20,215 common shares at $20.00, regardless of the market price at the time of exercise, if the options vest.
When do Yeshwant Krishna’s Parabilis (PBLS) stock options vest and become exercisable?
The options vest and become exercisable in full on the earlier of June 9, 2027 or the date of Parabilis Medicines’ next annual meeting of stockholders. Vesting is conditioned on his continued service as of that vesting date, according to the filing footnote.
What is the expiration date of the Parabilis (PBLS) stock options granted to the director?
The granted stock options expire on June 8, 2036 if not exercised. After that date, they can no longer be used to purchase Parabilis common stock at the $20.00 exercise price, effectively ending their value to the holder.
Is the Parabilis (PBLS) Form 4 transaction an open-market buy or a compensation grant?
The reported transaction is a compensation-related grant, not an open-market buy. The Form 4 lists transaction code A, described as a grant, award, or other acquisition, with a zero-dollar grant price and a $20.00 per share exercise price for future purchases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
